Palavra-chave: CARDIOVASCULAR DISEASES

TREATMENT GLYCOSYLATION END PRODUCTS, ADVANCED HEMODYALISIS UNITS DAPAGLIFLOZIN TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS) CKD-MBD STROKE ANTI-INFLAMMATORY COMPOUNDS NEUROPEPTIDE Y SOLUBLE FIBER UNCOUPLING PROTEIN-1 ADOLESCENT MORTALITY BONE DISEASES STATINS MICROBIOTA SEX DIFFERENCES NUTRIGENETIC ATHEROSCLEROSIS AGED METABOLIC SYNDROME RHEUMATOID ARTHRITIS LIPOPROTEINS HIPERCHOLESTEROLEMIA ALUMINUM PHARMACOLOGY INFLAMMATION AUTONOMIC NERVOUS SYSTEM PHOSPHATE THERMOGENESIS RISK FACTORS DIABETES EPIDEMIOLOGY OBESITY HDL CROSS-SECTIONAL STUDIES INSULIN RESISTANCE DRUG INTERACTIONS RENAL OSTEODYSTROPHY CHRONIC KIDNEY DISEASE TYPE 2 DIABETES HOSPITAL CORONARY ARTERY DISEASE CEREBROVASCULAR DISORDERS METFORMIN LIVER MITOCHONDRIA PARATHYROID HORMONE EXERCISE CETP (CHOLESTERYL ESTER TRANSFER PROTEIN) ATHEROSCLEROSIS RISK